Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,380 across all filing types
Latest filing 2021-06-16 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
上海康德莱企业发展集团股份有限公司关于H股公司境内未上市股份申请“全流通”事项申请材料获中国证监会受理的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the acceptance by the China Securities Regulatory Commission (CSRC) of an application related to the 'full circulation' of unlisted domestic shares of its H-share listed subsidiary. It details the board resolution, the submission of application materials, and the acceptance notice from the CSRC. The document does not contain financial statements, audit results, or detailed financial data. It is an official regulatory announcement about the status of an application for share circulation approval, not a financial report or detailed investor presentation. The document length is short (918 characters), and it serves as a regulatory update on the application process. Therefore, it fits best under Regulatory Filings (RNS).
2021-06-16 Chinese
关于股价异常波动询问函的回函
Regulatory Filings Classification · 95% confidence The document is a response letter to an inquiry about abnormal stock price fluctuations. It discusses the planning of a non-public exchangeable bond issuance and clarifies that no other undisclosed major matters are planned. The document is short (382 characters) and is a regulatory communication rather than a financial report or announcement of voting results, management changes, or capital changes. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement or compliance document.
2021-05-31 Chinese
上海康德莱企业发展集团股份有限公司股票交易异常波动公告
Regulatory Filings Classification · 100% confidence The document is a stock trading abnormal fluctuation announcement by Shanghai Kangdelai Enterprise Development Group Co., Ltd. It discusses the unusual price movements of the company's stock over several trading days, the company's investigation into the causes, confirmation of no undisclosed major matters except a planned private exchangeable bond issuance, and risk warnings to investors. The document does not contain financial statements or detailed financial data, nor is it a report or presentation. It is a regulatory announcement related to stock price movements and company disclosures. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1683 characters), and it is not an announcement of a report publication but a standalone disclosure.
2021-05-31 Chinese
上海康德莱企业发展集团股份有限公司第四届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution regarding a share conversion plan involving the company's H-share subsidiary. It details the board meeting date, attendance, agenda, and voting results. The content focuses on the approval of a share conversion proposal and related authorizations, with risk disclosures and procedural notes. There are no financial statements, quarterly or annual results, or detailed financial analysis. The document is a formal announcement of a board decision rather than a full management report or financial filing. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2021-05-25 Chinese
上海康德莱企业发展集团股份有限公司关于2020年限制性股票激励计划首次授予部分第一个解除限售期限制性股票解锁暨上市的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shanghai Kangdelai Enterprise Development Group Co., Ltd. regarding the unlocking and listing of restricted shares from the 2020 restricted stock incentive plan. It details the approval and implementation of the stock incentive plan, the conditions for lifting the lock-up period, the number of shares unlocked, and the legal opinions supporting the unlocking. The document is focused on the stock incentive plan and the unlocking of restricted shares, which is a capital/financing related update rather than a full financial report or management discussion. It is not an annual or interim report, earnings release, or governance report. It is also not a regulatory filing or announcement of a report publication. The content fits best under Capital/Financing Update (CAP) as it relates to stock incentives and share unlocking events affecting the company's capital structure.
2021-05-24 Chinese
北京安杰（上海）律师事务所关于上海康德莱企业发展集团股份有限公司2020年限制性股票激励计划首次授予部分限制性股票第一期解除限售相关事宜之法律意见书
Regulatory Filings
2021-05-24 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.